Your browser doesn't support javascript.
loading
Treatment of Latent Tuberculosis Infection Based on the Interferon-γ Release Assay in Allogeneic Stem Cell Transplant Recipients.
Park, Joung Ha; Choi, Eun-Ji; Park, Han-Seung; Choi, Sang-Ho; Lee, Sang-Oh; Kim, Yang Soo; Woo, Jun Hee; Lee, Jung-Hee; Lee, Je-Hwan; Lee, Kyoo-Hyung; Shim, Tae Sun; Kim, Sung-Han.
  • Park JH; Department of Infectious Diseases, Asan Medical Center, University of Ulsan College of Medicine, Seoul, South Korea.
  • Choi EJ; Department of Hematology, Asan Medical Center, University of Ulsan College of Medicine, Seoul, South Korea.
  • Park HS; Department of Hematology, Asan Medical Center, University of Ulsan College of Medicine, Seoul, South Korea.
  • Choi SH; Department of Infectious Diseases, Asan Medical Center, University of Ulsan College of Medicine, Seoul, South Korea.
  • Lee SO; Department of Infectious Diseases, Asan Medical Center, University of Ulsan College of Medicine, Seoul, South Korea.
  • Kim YS; Department of Infectious Diseases, Asan Medical Center, University of Ulsan College of Medicine, Seoul, South Korea.
  • Woo JH; Department of Infectious Diseases, Asan Medical Center, University of Ulsan College of Medicine, Seoul, South Korea.
  • Lee JH; Department of Hematology, Asan Medical Center, University of Ulsan College of Medicine, Seoul, South Korea.
  • Lee JH; Department of Hematology, Asan Medical Center, University of Ulsan College of Medicine, Seoul, South Korea.
  • Lee KH; Department of Hematology, Asan Medical Center, University of Ulsan College of Medicine, Seoul, South Korea.
  • Shim TS; Department of Pulmonology and Critical Care Medicine, Asan Medical Center, University of Ulsan College of Medicine, Seoul, South Korea.
  • Kim SH; Department of Infectious Diseases, Asan Medical Center, University of Ulsan College of Medicine, Seoul, South Korea.
Clin Infect Dis ; 71(8): 1977-1979, 2020 11 05.
Article en En | MEDLINE | ID: mdl-31930297
ABSTRACT
In hematopoietic stem cell transplant recipients, the incidence of tuberculosis in positive interferon-γ release assay (IGRA) without isoniazid prophylaxis (3.58/100 person-years) was higher than in negative or indeterminate IGRA (1.15/100 person-years; P = .01) and in positive IGRA with isoniazid prophylaxis (0/100 person-years; P = .09). The number needed to treat was 22 (95% confidence interval, 12-99) with positive IGRA results.
Asunto(s)
Palabras clave
Texto completo
Imprimir
XML
PubMed Links
Search on Google

Texto completo: 1 Banco de datos: MEDLINE Asunto principal: Trasplante de Células Madre Hematopoyéticas / Tuberculosis Latente Tipo de estudio: Diagnostic_studies Límite: Humans Idioma: En Año: 2020 Tipo del documento: Article
Texto completo
Imprimir
XML
PubMed Links
Search on Google

Texto completo: 1 Banco de datos: MEDLINE Asunto principal: Trasplante de Células Madre Hematopoyéticas / Tuberculosis Latente Tipo de estudio: Diagnostic_studies Límite: Humans Idioma: En Año: 2020 Tipo del documento: Article